Torrent Pharmaceuticals (NSE:TORNTPHARM) Common Stock: ₹1,692 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:TORNTPHARM Torrent Pharmaceuticals Ltd NSE:TORNTPHARM
85 GF Score
Price ₹5,065.20
GF Value ₹4,436.67
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Torrent Pharmaceuticals Common Stock?

Torrent Pharmaceuticals NSE:TORNTPHARM +0.63% 85 Common Stock is ₹1,692 Mil as of Mar. 2026. GuruFocus rates NSE:TORNTPHARM with a GF Score™ of 85/100 and a GF Value™ of ₹4,436.67 (Modestly Overvalued). The stock has 7 warning signs investors should review.

Torrent Pharmaceuticals's quarterly common stock declined from Sep. 2025 (₹1,690 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹1,692 Mil).

Torrent Pharmaceuticals's annual common stock stayed the same from Mar. 2024 (₹1,692 Mil) to Mar. 2025 (₹1,692 Mil) and stayed the same from Mar. 2025 (₹1,692 Mil) to Mar. 2026 (₹1,692 Mil).

Torrent Pharmaceuticals Common Stock Historical Data

* Premium members only.

The historical data trend for Torrent Pharmaceuticals's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Torrent Pharmaceuticals Common Stock Chart

Torrent Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 846.20 1,692.30 1,692.30 1,692.30 1,692.30

Torrent Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,692.30 0.00 1,690.00 0.00 1,692.30
NSE:TORNTPHARM
85GF Score
Torrent Pharmaceuticals Ltd NSE:TORNTPHARM
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Torrent Pharmaceuticals Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of ₹1,692 Mil mean?
Torrent Pharmaceuticals (NSE:TORNTPHARM) has a Common Stock of ₹1,692 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Torrent Pharmaceuticals and its competitors.
Is Torrent Pharmaceuticals' Common Stock too high?
Torrent Pharmaceuticals' current Common Stock is ₹1,692 Mil. Overall, Torrent Pharmaceuticals has a GF Score™ of 85/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Torrent Pharmaceuticals' Common Stock compare to ZTS and UTHR?
Torrent Pharmaceuticals' Common Stock of ₹1,692 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Torrent Pharmaceuticals and its competitors. Torrent Pharmaceuticals's current Common Stock is ₹1,692 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Torrent Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Torrent Pharmaceuticals (NSE:TORNTPHARM) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹4,436.67, compared to a current price of ₹5,065.20 — trading 14.2% above its estimated fair value. The current Common Stock is ₹1,692 Mil. Torrent Pharmaceuticals' overall GF Score™ is 85/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Torrent Pharmaceuticals (NSE:TORNTPHARM), the current Common Stock is ₹1,692 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Torrent Pharmaceuticals (NSE:TORNTPHARM) Overvalued in 2026?

Based on GuruFocus' analysis, Torrent Pharmaceuticals stock appears to be overvalued. The current stock price of ₹5,065.20 is trading 14.2% above its estimated GF Value™ of ₹4,436.67. GuruFocus considers Torrent Pharmaceuticals to be Modestly Overvalued.

Key valuation signals for NSE:TORNTPHARM:

  • Common Stock: ₹1,692 Mil
  • GF Value™: ₹4,436.67 vs. price of ₹5,065.20 (14.2% above fair value)
  • GF Score™: 85/100 with 7 warning signs

No single metric tells the full story. See the NSE:TORNTPHARM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Torrent Pharmaceuticals Business Description

Other Exchanges 500420:India
Address Off Ashram Road, Torrent House, Ahmedabad, GJ, IND, 380009
Torrent Pharmaceuticals Ltd is a drug manufacturing company with a focus on the cardiovascular, central nervous system, Vitamins Minerals Nutrients (VMN), and gastrointestinal therapeutic areas. It operates through the Generic Formulation Business segment. Geographically, the business activities are carried out across Indian and International markets. Maximum revenue for the company is generated from its operations in India.
85GF Score

Get the complete analysis for NSE:TORNTPHARM

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹5,065.20
Price
₹4,436.67
GF Value